The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The quality of life in neoadjuvant versus adjuvant therapy of esophageal cancer treatment trial (QUINTETT).
 
Richard Malthaner
No Relationships to Disclose
 
Edward Yu
No Relationships to Disclose
 
Michael Susmoy Sanatani
No Relationships to Disclose
 
Debra Lewis
No Relationships to Disclose
 
Andrew Warner
No Relationships to Disclose
 
A. Rashid Dar
No Relationships to Disclose
 
Brian P Yaremko
No Relationships to Disclose
 
Joel Bierer
No Relationships to Disclose
 
David A. Palma
No Relationships to Disclose
 
George Rodrigues
No Relationships to Disclose
 
Dalilah Fortin
No Relationships to Disclose
 
Richard Inculet
No Relationships to Disclose
 
Eric Frechette
No Relationships to Disclose
 
Jacques Raphael
No Relationships to Disclose
 
Steward Gaede
No Relationships to Disclose
 
Sarah Kuruvilla
No Relationships to Disclose
 
Jawaid Younus
No Relationships to Disclose
 
Mark David Vincent
Leadership - Aptose Biosciences
Honoraria - Amgen; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Lilly; Lilly; Merck; Novartis; Roche Canada; Sanofi
Consulting or Advisory Role - Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Lilly; Merck; Novartis; Roche
Speakers' Bureau - Lilly
Patents, Royalties, Other Intellectual Property - CEO Sarissa Inc., and patent holder of two non-commercialized patents
Travel, Accommodations, Expenses - AstraZeneca; Boehringer Ingelheim; Lilly; Roche Canada